Aura Biosciences (AURA) Treasury Shares (2020 - 2026)
Aura Biosciences' (AURA) quarterly Treasury Shares came in at $3.3 million in Q1 2026, up 19.42% YoY from $2.8 million in Q1 2025, and up 22.13% on a QoQ basis from $2.7 million in Q4 2025.
Aura Biosciences (AURA) Treasury Shares (2020 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 7 years of Treasury Shares data on file, last reported at $3.3 million in Q1 2026.
- Quarterly Treasury Shares rose 19.42% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 19.42% YoY) and the FY2025 annual result came in at $2.7 million, up 69.33% from the prior year.
- Treasury Shares improved to $3.3 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.3 million in Q1 2026 to a low of $153950.0 in Q4 2022.
- A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares tumbled 99.8% — and 2023, when it jumped 610.23%.
- Tracing AURA's Treasury Shares over 5 years: stood at $153950.0 in 2022, then jumped by 610.23% to $1.1 million in 2023, then surged by 45.33% to $1.6 million in 2024, then soared by 69.33% to $2.7 million in 2025, then gained by 22.13% to $3.3 million in 2026.
- The last three Treasury Shares figures came in at $3.3 million (Q1 2026), $2.7 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Aura Biosciences | 797.49 Mn | 729.65 Mn | - | 39.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.10 Mn |
| Jun 30, 2026 | 39.10 Mn |
| Jun 30, 2026 | 6.92 Mn |
| Jun 30, 2026 | 6.92 Mn |
| Mar 31, 2026 | 3.29 Mn |
| Mar 31, 2026 | 3.29 Mn |
| Dec 31, 2025 | 2.69 Mn |
| Dec 31, 2025 | 2.69 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Sep 30, 2025 | 2.81 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.82 Mn |
| Mar 31, 2025 | 2.75 Mn |
| Mar 31, 2025 | 2.75 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.76 Mn |